ReP USP - Resultado da busca

Artigo de periodico
Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice (2024)
Barbosa, Pedro F.; Gonçalves, Diego S.; Ramos, Lívia de Souza ; Mello, Thaís P.; Braga-Silva, Lys A.; Pinto, Marcia R.; Branquinha, Marta H. ; Santos, André L. S. ; Taborda, Carlos Pelleschi
Source: Infectious Disease Reports. Unidade: ICB
Subjects: MICROBIOLOGIA, CITOMETRIA DE FLUXO, CAMUNDONGOS, INTERAÇÃO CELULAR, ENZIMAS HIDROLÍTICAS, CANDIDA ALBICANS, FUNGOS MITOSPORICOS, IMUNOGLOBULINAS, NITROGÊNIO, ANTÍGENOS DE FUNGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Pedro F. et al. Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, v. 16, n. 4, p. 572-586, 2024Tradução . . Disponível em: https://doi.org/10.3390/idr16040043. Acesso em: 02 nov. 2024.
APA
Barbosa, P. F., Gonçalves, D. S., Ramos, L. de S., Mello, T. P., Braga-Silva, L. A., Pinto, M. R., et al. (2024). Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, 16( 4), 572-586. doi:https://doi.org/10.3390/idr16040043
NLM
Barbosa PF, Gonçalves DS, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/idr16040043
Vancouver
Barbosa PF, Gonçalves DS, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/idr16040043
Artigo de periodico
Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice (2024)
Barbosa, Pedro F.; Gonçalves, Diego de Souza ; Ramos, Lívia de Souza ; Mello, Thais P. ; Braga-Silva, Lys A.; Pinto, Marcia R.; Branquinha, Marta H. ; Santos, André L. S. ; Taborda, Carlos Pelleschi
Source: Infectious Disease Reports. Unidade: IMT
Subjects: MICROBIOLOGIA, INIBIDORES DE ENZIMAS, ANTÍGENOS DE FUNGOS, FUNGOS MITOSPORICOS, CAMUNDONGOS, ALBUMINAS, CÉLULAS EPITELIAIS, MACRÓFAGOS, LEVEDURAS, CANDIDA ALBICANS, INFECÇÕES BACTERIANAS E MICOSES, CITOMETRIA DE FLUXO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Pedro F. et al. Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, v. 16, n. 4, p. 572-586, 2024Tradução . . Disponível em: https://doi.org/10.3390/idr16040043. Acesso em: 02 nov. 2024.
APA
Barbosa, P. F., Gonçalves, D. de S., Ramos, L. de S., Mello, T. P., Braga-Silva, L. A., Pinto, M. R., et al. (2024). Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, 16( 4), 572-586. doi:10.3390/idr16040043
NLM
Barbosa PF, Gonçalves D de S, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/idr16040043
Vancouver
Barbosa PF, Gonçalves D de S, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/idr16040043
Artigo de periodico
Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches (2021)
Santos, André L. S. ; Silva, Lys A. Braga; Gonçalves, Diego de Souza ; Ramos, Lívia de Souza ; Oliveira, Simone S. C.; Souza, Lucieri O. P.; Oliveira, Vanessa S.; Lins, Roberto D. ; Pinto, Marcia R.; Muñoz, Julian E. ; Taborda, Carlos Pelleschi ; Branquinha, Marta H.
Source: Journal of Fungi. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTIRRETROVIRAIS, INFECÇÕES POR HIV, CANDIDA ALBICANS, ENZIMAS HIDROLÍTICAS, BIOFILMES, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, André L. S. et al. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches. Journal of Fungi, v. 7, n. 6, p. 1-33, 2021Tradução . . Disponível em: https://doi.org/10.3390/jof7060424. Acesso em: 02 nov. 2024.
APA
Santos, A. L. S., Silva, L. A. B., Gonçalves, D. de S., Ramos, L. de S., Oliveira, S. S. C., Souza, L. O. P., et al. (2021). Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches. Journal of Fungi, 7( 6), 1-33. doi:10.3390/jof7060424
NLM
Santos ALS, Silva LAB, Gonçalves D de S, Ramos L de S, Oliveira SSC, Souza LOP, Oliveira VS, Lins RD, Pinto MR, Muñoz JE, Taborda CP, Branquinha MH. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches [Internet]. Journal of Fungi. 2021 ; 7( 6): 1-33.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/jof7060424
Vancouver
Santos ALS, Silva LAB, Gonçalves D de S, Ramos L de S, Oliveira SSC, Souza LOP, Oliveira VS, Lins RD, Pinto MR, Muñoz JE, Taborda CP, Branquinha MH. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches [Internet]. Journal of Fungi. 2021 ; 7( 6): 1-33.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/jof7060424

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation